Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity

Clowes, 1996, Improving the interface between biomaterials and the blood. The gene therapy approach, Circulation, 93, 1319, 10.1161/01.CIR.93.7.1319 Wissink, 2000, Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices, J. Control. Release, 64, 103, 10.1016/S0168-3659(99)00145-5 Gray, 1994, FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia, J. Surg. Res., 57, 596, 10.1006/jsre.1994.1189 Kang, 1995, Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions, Surgery, 118, 280, 10.1016/S0039-6060(05)80335-6 Greisler, 1992, Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment, Surgery, 112, 244 Shireman, 1998, Fibrin sealant in vascular surgery: a review, J. Long-Term Eff. Med. Implants, 8, 117 Zilla, 1989, Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts, Surgery, 105, 515 Merzkirch, 2001, Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides?, Anat. Rec., 263, 379, 10.1002/ar.1118 Deutsch, 1997, In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation, J. Vasc. Surg., 25, 757, 10.1016/S0741-5214(97)70307-0 Weatherford, 1996, Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition, Surgery, 120, 433, 10.1016/S0039-6060(96)80320-5 Shireman, 1999, Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions, J. Vasc. Surg., 29, 852, 10.1016/S0741-5214(99)70213-2 Ehrbar, 2004, Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth, Circ. Res., 94, 1124, 10.1161/01.RES.0000126411.29641.08 Zisch, 2003, Biopolymeric delivery matrices for angiogenic growth factors, Cardiovasc. Pathol., 12, 295, 10.1016/S1054-8807(03)00089-9 Sakiyama-Elbert, 2001, Development of growth factor fusion proteins for cell-triggered drug delivery, FASEB J., 15, 1300, 10.1096/fj.00-0564fje Zisch, 2001, Covalently conjugated VEGF-fibrin matrices for endothelialization, J. Control. Release, 72, 101, 10.1016/S0168-3659(01)00266-8 Zisch, 2003, Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth, FASEB J., 17, 2260, 10.1096/fj.02-1041fje Seliktar, 2004, MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing, J. Biomed. Mater. Res., 68A, 704, 10.1002/jbm.a.20091 Lutolf, 2003, Cell-responsive synthetic hydrogels, Adv. Mater., 15, 888, 10.1002/adma.200304621 Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 Stump, 1963, Endothelium grown from circulating blood on isolated intravascular dacron hub, Am. J. Pathol., 43, 361 Shi, 1998, Evidence for circulating bone marrow-derived endothelial cells, Blood, 92, 362, 10.1182/blood.V92.2.362 Rafii, 2003, Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration, Nat. Med., 9, 702, 10.1038/nm0603-702 Assmus, 2002, Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI), Circulation, 106, 3009, 10.1161/01.CIR.0000043246.74879.CD Murohara, 2001, Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors, Trends Cardiovasc. Med., 11, 303, 10.1016/S1050-1738(01)00128-1 Kalka, 2000, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, Proc. Natl. Acad. Sci. U. S. A., 97, 3422, 10.1073/pnas.070046397 Dimmeler, 2001, HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, J. Clin. Invest., 108, 391, 10.1172/JCI200113152 Kaushal, 2001, Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo, Nat. Med., 7, 1035, 10.1038/nm0901-1035 Schense, 1999, Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa, Bioconjug. Chem., 10, 75, 10.1021/bc9800769 Ferrara, 2003, The biology of VEGF and its receptors, Nat. Med., 9, 669, 10.1038/nm0603-669 Peichev, 2000, Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors, Blood, 95, 952, 10.1182/blood.V95.3.952.003k27_952_958 Sakiyama-Elbert, 2000, Development of fibrin derivatives for controlled release of heparin-binding growth factors, J. Control. Release, 65, 389, 10.1016/S0168-3659(99)00221-7